• GRI Bio shareholders approved adding 546,529 common shares to the equity incentive plan at the November 4, 2026, annual meeting.
• The plan amendment also received approval to extend its evergreen provision to January 1, 2036.
• Shareholders elected two directors, including David Szekeres.
• WithumSmith+Brown, PC was ratified as independent auditor for the fiscal year ending December 31, 2026.
• Shareholders authorized postponement or adjournment if needed to solicit additional proxies for proposals lacking sufficient votes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gri Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001824293-26-000063), on November 04, 2026, and is solely responsible for the information contained therein.